RETA | Reata Pharmaceuticals Inc
Category: Consumer goods
Quick infos Headquarters: Irving, Texas, United States Trade prices Volume: Market Cap: 914.66M Prev closed: 138.63 Open: 138.74 High: 144.68 Low: 131.76 52 week low: 76.34 52 week high: 186.82 Dividends: No Dividends Next ER: May 10, 2022 Before Market Opens
About the Company Reata Pharmaceuticals, Inc. is a pharmaceutical company based in Plano, Texas. Founded in 2002, Reata is primarily focused on investigating experimental oral antioxidative and anti-inflammatory drugs, ...
Earnings History Date EPS / Forecast Revenue / Forecast August 10, 2022 May 10, 2022 -1.33 / -2.170.91M / 1.35MFebruary 28, 2022 -2.35 / -2.26934K / 1.63MBeat! November 8, 2021 -1.97 / -2.177.39M / 2.07MBeat! August 9, 2021 -2 / -1.882.22M / 1.25MBeat! view more
Historical Data Date Price Open High Low Vol Change ER May 9, 2022 20.71 22.39 22.70
20.23
788.45K -10.39% May 6, 2022 23.11 24.80 24.80
22.64
507.68K -7.89% May 5, 2022 25.09 26.69 26.70
24.30
356.52K -7.07% May 4, 2022 27.00 26.51 27.18
24.89
304.01K 1.89% May 3, 2022 26.50 27.00 27.84
25.68
279.62K -1.49% May 2, 2022 26.90 25.34 27.22
25.04
466.19K 5.99% Apr 29, 2022 25.38 26.58 27.87
25.18
433.13K -3.9% Apr 28, 2022 26.41 26.48 26.66
24.29
771.35K 1.93% Apr 27, 2022 25.91 26.66 27.30
25.77
709.28K -3.03% Apr 26, 2022 26.72 28.72 29.24
26.34
499.09K -8.62% view more
NASDAQ - Nasdaq Stock Market
More profiles and info about the company Founded:2002 Employees:123 News
Why Reata Pharmaceuticals Nose-Dived on Monday fool.com Dec 9, 2021 5:18 pm
Reata Pharmaceuticals, Inc. Announces Second Quarter 2021 Financial Results and Provides an Update on Clinical Development Programs finance.yahoo.com Dec 9, 2021 4:01 pm
Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Reata Pharmaceuticals, Inc. (RETA) Investigation finance.yahoo.com Dec 9, 2021 2:30 pm
FINAL DEADLINE MONDAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Reata Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm finance.yahoo.com Dec 9, 2021 2:00 pm
DEADLINE FOR RETA INVESTORS: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Reata Pharmaceuticals Inc. finance.yahoo.com Dec 9, 2021 1:30 pm
Reata Pharma Shares Are Trading Higher After Filing US Application In Alport Syndrome-Related Kidney Disease finance.yahoo.com Dec 9, 2021 12:54 pm
The Law Offices of Frank R. Cruz Announces Investigation of Reata Pharmaceuticals, Inc. (RETA) on Behalf of Investors finance.yahoo.com Dec 9, 2021 12:15 pm
RETA, EOLS & TRQ Class Actions: Bronstein, Gewirtz & Grossman LLC Reminds Investors of Class Actions and Encourages Investors to Contact the Firm finance.yahoo.com Dec 9, 2021 11:00 am
RETA, EOLS & TRQ Class Actions: Bronstein, Gewirtz & Grossman LLC Reminds Shareholders of Class Actions and Encourages Investors to Contact the Firm finance.yahoo.com Dec 9, 2021 11:00 am
DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Reata Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm finance.yahoo.com Dec 9, 2021 10:36 am
Is RETA Stock A Buy or Sell? finance.yahoo.com Dec 9, 2021 10:22 am
RETA INVESTIGATION: Hagens Berman, National Trial Attorneys, Encourages Reata Pharmaceuticals, Inc. (RETA) Investors to Contact Firm's Attorneys, Firm Investigating Possible Securities Law Violations finance.yahoo.com Dec 9, 2021 10:07 am
Did You Miss Reata Pharmaceuticals' (NASDAQ:RETA) Whopping 681% Share Price Gain? finance.yahoo.com Dec 9, 2021 9:51 am
Strength Seen in Reata Pharmaceuticals, Inc. (RETA): Can Its 3% Jump Turn into More Strength? finance.yahoo.com Dec 9, 2021 8:47 am
Portnoy Law: Lawsuit Filed On Behalf of Reata Pharmaceuticals, Inc. Investors finance.yahoo.com Dec 9, 2021 8:00 am
Reata Pharmaceuticals, Inc. (RETA) Reports Q3 Loss, Tops Revenue Estimates finance.yahoo.com Dec 9, 2021 7:55 am
Reata Pharmaceuticals, Inc. to Report Third Quarter 2021 Financial Results and to Provide an Update on Development Programs on November 8, 2021 finance.yahoo.com Dec 9, 2021 7:47 am
We Think Reata Pharmaceuticals (NASDAQ:RETA) Can Afford To Drive Business Growth finance.yahoo.com Dec 9, 2021 7:20 am
Reata Announces that The FDA Has Asked The Company to Request a Pre-NDA Meeting for Omaveloxolone for the Treatment of Friedreichs Ataxia finance.yahoo.com Dec 9, 2021 6:45 am
3 Beaten-Down Biotech Stocks -- Are They Bargains Now? fool.com Dec 9, 2021 5:57 am This company doesn't provide a dividend.
Key Persons CFO : Jason Wilson Chief Medical Officer : Seemi Khan Talk about Reata Pharmaceuticals Inc below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
Consensus
If you want to help pay for server cost or for improving this tool. You can send it via Paypal .
Buy on Amazon While many books explain the how of bitcoin, The Internet of Money delves into the why of bitcoin. Acclaimed information-security expert and author of Mastering Bitcoin, Andreas M. Antonopoulos examines and contextualizes the significance of bitcoin through a series of essays spanning the exhilarating maturation of this technology.
